Organization
Niguarda Hospital, Unit of Allergy and Clinical Immunology, Milano, Italy
1 abstract
Abstract
BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): RESULTS FROM A EUROPEAN MULTICENTER STUDY ON 121 PATIENTSOrg: University of Florence, Department of Experimental and Clinical Medicine, Florence, Italy, University of Padova, Department of Medicine DIMED, Padova, Italy, Hôpital Foch, Department of Internal Medicine, Suresnes, France, University of Bari, Department of Precision and Rigenerative Medicine and Ionian Area, Bari, Italy, Addenbrookes Hospital, Department of Medicine, Cambridge, United Kingdom,